A federal judge approved a $40 million class-action settlement Monday between Skechers USA Inc. and consumers who bought toning shoes after ads made unfounded claims that the footwear would help people lose weight and strengthen muscles.
U.S. District Judge Thomas B. Russell in Louisville approved the deal, which covers more than 520,000 claims. About 1,000 people eligible for coverage by the settlement opted not to take part.
Those with approved claims will be able to get a maximum repayment for their purchase _ up to $80 per pair of Shape-Ups; $84 per pair of Resistance Runner shoes; up to $54 per pair of Podded Sole Shoes; and $40 per pair of Tone-Ups.
Russell also awarded $5 million for the attorneys in the case to split. Russell ordered that the money cannot come from the $40 million settlement fund set aside for consumers.
Two people that served as the lead plaintiffs in the case will receive payments of $2,500 each.
Russell considered multiple factors in deciding to approve the settlement and found it provides just compensation to the plaintiffs.
Thursday, May 23, 2013
Monday, April 8, 2013
Ex-Goldman trader pleads guilty in NY fraud probe
A former Goldman Sachs trader pleaded guilty to wire fraud Wednesday, admitting that he caused his company to lose $118 million in 2007 when he put $8 billion at risk.
Matthew Marshall Taylor, 34, said he took the position on a futures contract traded electronically through the Chicago Mercantile Exchange in December 2007 to enhance his reputation and boost his earnings in a year when he made $150,000 in salary and $1.6 million in bonuses. At the time, he was working at Goldman Sachs in lower Manhattan.
According to court papers filed in Manhattan, Taylor entered fictitious information in trading account records and lied to company representatives to cover up the fact that he had put 10 times more money at risk in the trade than he was allowed. He claimed that the $8 billion at risk was actually only $65 million, the papers said.
U.S. District Judge William H. Pauley III said he was miffed that the government in a plea deal was holding Taylor responsible for no more than $2.5 million in losses. The amount of money lost in financial crimes usually plays a significant role in the length of any prison sentence.
The judge also said he could not understand why the government was not making a legal finding that Taylor had used "sophisticated means" to carry out the crime. Such a designation would again likely increase the length of any prison sentence. Pauley also noted that the government could have claimed that the crime endangered the financial health of Goldman Sachs, a designation that also could increase a prison sentence. A prosecutor said he did not believe either enhancement was appropriate because Taylor carried out the fraud in a manner similar to his usual work patterns and the company's financial stability was not threatened.
Matthew Marshall Taylor, 34, said he took the position on a futures contract traded electronically through the Chicago Mercantile Exchange in December 2007 to enhance his reputation and boost his earnings in a year when he made $150,000 in salary and $1.6 million in bonuses. At the time, he was working at Goldman Sachs in lower Manhattan.
According to court papers filed in Manhattan, Taylor entered fictitious information in trading account records and lied to company representatives to cover up the fact that he had put 10 times more money at risk in the trade than he was allowed. He claimed that the $8 billion at risk was actually only $65 million, the papers said.
U.S. District Judge William H. Pauley III said he was miffed that the government in a plea deal was holding Taylor responsible for no more than $2.5 million in losses. The amount of money lost in financial crimes usually plays a significant role in the length of any prison sentence.
The judge also said he could not understand why the government was not making a legal finding that Taylor had used "sophisticated means" to carry out the crime. Such a designation would again likely increase the length of any prison sentence. Pauley also noted that the government could have claimed that the crime endangered the financial health of Goldman Sachs, a designation that also could increase a prison sentence. A prosecutor said he did not believe either enhancement was appropriate because Taylor carried out the fraud in a manner similar to his usual work patterns and the company's financial stability was not threatened.
Tuesday, February 5, 2013
Price Waicukauski & Riley, LLC - Class Actions
Class action lawyers must be experienced with complex litigation and class action certification, notice, and settlement procedures. Large corporate defendants always put up formidable opposition in cases involving thousands of claimants.
Our experienced Indiana based class action lawyers have the willingness to tackle the most complex of cases and aggressively face larger law firms and corporations on your behalf. Our class action attorneys have represented plaintiff classes in numerous class action lawsuits. Among the major class action lawsuits we have handled are:
Right-of-Way Class Action Lawsuits
Pharmaceutical and Prescription Drug Class Actions
Medical Device Class Actions
Personal Injury Multidistrict and Class Actions
Financial Damage Class Actions
Property Owner Class Actions
http://www.price-law.com/practice-areas/class-actions
Our experienced Indiana based class action lawyers have the willingness to tackle the most complex of cases and aggressively face larger law firms and corporations on your behalf. Our class action attorneys have represented plaintiff classes in numerous class action lawsuits. Among the major class action lawsuits we have handled are:
Right-of-Way Class Action Lawsuits
Pharmaceutical and Prescription Drug Class Actions
Medical Device Class Actions
Personal Injury Multidistrict and Class Actions
Financial Damage Class Actions
Property Owner Class Actions
http://www.price-law.com/practice-areas/class-actions
Thursday, January 3, 2013
Fiscal cliff deal forged in flurry of final talks
Stuck in a "fiscal cliff" stalemate, trust nearing tatters, President Barack Obama and Senate Republicans changed the game after Christmas. It took the rekindling of an old friendship between Vice President Joe Biden and GOP Sen. Mitch McConnell, an extraordinary flurry of secret offers, a pre-dawn Senate vote on New Year's Day and the legislative muscling that defines Washington on deadline.
The House, despite Republican resistance, passed the Senate bill late Tuesday, sending the measure to Obama for his signature.
How the final days of private negotiations pulled the country back from the precipice of the fiscal cliff marked a rare moment of bipartisanship for a divided government. Several officials familiar with talks requested anonymity to discuss them because they were not authorized to discuss the private details publicly.
Obama, having cut short his Christmas vacation in Hawaii, huddled with congressional leaders Friday afternoon at the White House. Talks between the president and House Speaker John Boehner had failed, so Obama put the fate of the fiscal cliff in the hands of McConnell and Senate Majority Leader Harry Reid.
McConnell made the first move. The Kentucky Republican proposed a plan late Friday night that would extend tax cuts expiring Jan. 1 on family income up to $750,000 a year, according to officials. He also wanted to keep tax rates on wealthy estates at 35 percent, slow the growth of Social Security cost-of-living increases, and pay for an offset of the sequester — Congress's term for across-the-board spending cuts __ by means-testing Medicare. His offer did not include the extension of unemployment benefits Obama had demanded.
The House, despite Republican resistance, passed the Senate bill late Tuesday, sending the measure to Obama for his signature.
How the final days of private negotiations pulled the country back from the precipice of the fiscal cliff marked a rare moment of bipartisanship for a divided government. Several officials familiar with talks requested anonymity to discuss them because they were not authorized to discuss the private details publicly.
Obama, having cut short his Christmas vacation in Hawaii, huddled with congressional leaders Friday afternoon at the White House. Talks between the president and House Speaker John Boehner had failed, so Obama put the fate of the fiscal cliff in the hands of McConnell and Senate Majority Leader Harry Reid.
McConnell made the first move. The Kentucky Republican proposed a plan late Friday night that would extend tax cuts expiring Jan. 1 on family income up to $750,000 a year, according to officials. He also wanted to keep tax rates on wealthy estates at 35 percent, slow the growth of Social Security cost-of-living increases, and pay for an offset of the sequester — Congress's term for across-the-board spending cuts __ by means-testing Medicare. His offer did not include the extension of unemployment benefits Obama had demanded.
Thursday, November 8, 2012
Jordan court postpones verdict of ex-spy chief
A Jordanian criminal court says it has postponed a verdict in the case of a powerful former intelligence chief on trial for alleged embezzlement of public funds, money laundering and abuse of office.
Presiding judge Nashaat Akhras told Mohammed al-Dahabi in court Sunday that his verdict will be pronounced Nov. 11, without giving a reason.
Al-Dahabi ran the General Intelligence Department between 2005 and 2008.
He faces up to 15 years in jail if convicted.
He was arrested in February, when inspectors from the Central Bank of Jordan suspected transactions worth millions of dollars had gone through his bank account.
The rare case against such a high profile official is meant to show Jordan's seriousness in efforts to tackle graft and corruption — a demand voiced in recent street protests.
Presiding judge Nashaat Akhras told Mohammed al-Dahabi in court Sunday that his verdict will be pronounced Nov. 11, without giving a reason.
Al-Dahabi ran the General Intelligence Department between 2005 and 2008.
He faces up to 15 years in jail if convicted.
He was arrested in February, when inspectors from the Central Bank of Jordan suspected transactions worth millions of dollars had gone through his bank account.
The rare case against such a high profile official is meant to show Jordan's seriousness in efforts to tackle graft and corruption — a demand voiced in recent street protests.
Wednesday, October 17, 2012
Experienced Pharmaceutical Litigation Attorneys
Pharamaceutical Drug Litigation often arises when drugs are not properly tested. Because the process of the FDA's trials and approval process is often rushed through, prescripton drugs may prose a problem for putting consumers at risk for harmful drugs. These drug approvals that were not done properly result in thousands of deaths each year in America and many others suffer from harmful reactions and debilitating side effects from insufficiently tested pharmaceutical drugs.
Driving a successful claim against the pharmaceutical giants demands an experienced and knowledgeable pharmaceutical drug lawyer.
A Reputation for Success
With over 20 years of experience, the attorneys of Price, Waicukauski & Riley truly understand the pharmaceutical industry, laws and litigation process. As a result, we can provide you with sound advice and quality representation.
Our attorneys have represented hundreds of plaintiffs in litigations throughout the country involving a wide variety of prescription and over-the-counter drugs. Our attorneys have served on plaintiff steering committees across the nation in several different prescription drug and medical device litigations. We have been involved in several groundbreaking pharmaceutical and prescription drug cases, including:
Darvocet and Darvon
Kugel Mesh Hernia Patch
LEVAQUIN® (Generic Name: Levofloxacin)
ORTHO EVRA®
With extensive experience representing clients in product-related class action litigation and mass tort litigation, we offer you proven knowledge, experience and resources to represent you against the largest pharmaceutical companies.
Contact Us for a Complimentary Consultation
For experienced pharmaceutical drug representation, contact the attorneys at Price Waicukauski & Riley, LLC, in Indianapolis, Indiana. We represent clients throughout Indiana and the United States. We provide a free initial consultation on all pharmaceutical drug claims. http://www.price-law.com/practice-areas/pharmaceutical-drug-litigation
Driving a successful claim against the pharmaceutical giants demands an experienced and knowledgeable pharmaceutical drug lawyer.
A Reputation for Success
With over 20 years of experience, the attorneys of Price, Waicukauski & Riley truly understand the pharmaceutical industry, laws and litigation process. As a result, we can provide you with sound advice and quality representation.
Our attorneys have represented hundreds of plaintiffs in litigations throughout the country involving a wide variety of prescription and over-the-counter drugs. Our attorneys have served on plaintiff steering committees across the nation in several different prescription drug and medical device litigations. We have been involved in several groundbreaking pharmaceutical and prescription drug cases, including:
Darvocet and Darvon
Kugel Mesh Hernia Patch
LEVAQUIN® (Generic Name: Levofloxacin)
ORTHO EVRA®
With extensive experience representing clients in product-related class action litigation and mass tort litigation, we offer you proven knowledge, experience and resources to represent you against the largest pharmaceutical companies.
Contact Us for a Complimentary Consultation
For experienced pharmaceutical drug representation, contact the attorneys at Price Waicukauski & Riley, LLC, in Indianapolis, Indiana. We represent clients throughout Indiana and the United States. We provide a free initial consultation on all pharmaceutical drug claims. http://www.price-law.com/practice-areas/pharmaceutical-drug-litigation
Monday, August 6, 2012
NJ court upholds decal law for young drivers
Young drivers in New Jersey will have to continue displaying a red decal on their license plates.
The state Supreme Court upheld "Kyleigh's Law" in a ruling Monday.
In a unanimous opinion, the high court ruled that requiring the decals doesn't violate federal privacy laws or laws against unreasonable search and seizure. An appeals court had ruled similarly last year in a challenge brought by two parents.
The law is named for a New Jersey teenager who was killed in a 2006 crash. It's meant to aid police in enforcing restricted privileges for young drivers.
Opponents say displaying the decals could leave teen drivers vulnerable to predators. But a report last year found only one reported incident in which an underage driver was stopped by someone impersonating a police officer.
The state Supreme Court upheld "Kyleigh's Law" in a ruling Monday.
In a unanimous opinion, the high court ruled that requiring the decals doesn't violate federal privacy laws or laws against unreasonable search and seizure. An appeals court had ruled similarly last year in a challenge brought by two parents.
The law is named for a New Jersey teenager who was killed in a 2006 crash. It's meant to aid police in enforcing restricted privileges for young drivers.
Opponents say displaying the decals could leave teen drivers vulnerable to predators. But a report last year found only one reported incident in which an underage driver was stopped by someone impersonating a police officer.
Subscribe to:
Posts (Atom)